Assessment of common red blood cell pretreatments to yield an accurate serologic antigen phenotype compared with genotype-predicted phenotype

1.Shulman IA. Prophylactic phenotype matching of donors for the transfusion of nonalloimmunized patients with sickle cell disease. Immunohematology 2006;22:101–2.10.21307/immunohematology-2019-363Search in Google Scholar

2.Chou ST, Friedman DF. Transfusion practices for patients with sickle cell disease at the Children’s Hospital of Philadelphia. Immunohematology 2012;28:27–30.10.21307/immunohematology-2019-146Search in Google Scholar

3.Fasano RM, Chou ST. Red blood cell antigen genotyping for sickle cell disease, thalassemia, and other transfusion complications. Transfus Med Rev 2016;30:197–201.10.1016/j.tmrv.2016.05.01127345938Search in Google Scholar

4.Meny GM. Transfusion protocols for patients with sickle cell disease: working toward consensus? Immunohematology 2012;28:1–2.10.21307/immunohematology-2019-139Search in Google Scholar

5.Matteocci A, Pierelli L. Red blood cell alloimmunization in sickle cell disease and in thalassaemia: current status, future perspectives and potential role of molecular typing. Vox Sang 2014;106:197–208.10.1111/vox.1208624117723Search in Google Scholar

6.Fung MK, Eder AF, Spitalnik S, Westhoff CM, Eds. Technical manual. 19th ed. Bethesda, MD: AABB.Search in Google Scholar

7.Burin des Roziers N, Squalli S. Removing IgG antibodies from intact red cells: comparison of acid and EDTA, heat, and chloroquine elution methods. Transfusion 1997;37:497–501.10.1046/j.1537-2995.1997.37597293880.x9149774Search in Google Scholar

8.Sandler SG, Horn T, Keller J, Langeberg A, Keller MA. A model for integrating molecular-based testing in transfusion services. Blood Transfus 2015;14:566–72.Search in Google Scholar

9.Hashmi G, Shariff T, Zhang Y, et al. Determination of 24 minor red blood cell antigens for more high-throughput DNA analysis. Transfusion 2007;47:736–47. Erratum in: Transfusion 2007;47:952.Search in Google Scholar

10.Belsito A, Magnussen K, Napoli C. Emerging strategies of blood group genotyping for patients with hemoglobinopathies. Transfus Apher Sci 2017;56:206–13.10.1016/j.transci.2016.11.00728040400Search in Google Scholar

11.da Costa DC, Pellegrino J Jr, Guelsin GA, Ribeiro KA, Gilli SC, Castilho L. Molecular matching of red blood cells is superior to serological matching in sickle cell disease patients. Rev Bras Hematol Hemoter 2013;35:35–8.10.5581/1516-8484.20130012362163323580882Search in Google Scholar

12.Tournamille C, Le Van Kim C, Gane P, et al. Arg89Cys substitution results in very low membrane expression of the Duffy antigen/receptor for chemokines in Fy(x) individuals. Blood 1998;92:2147–56. Erratum in: Blood 2000;95:2753.Search in Google Scholar

13.Arndt PA, Horn T, Keller JA, Heri SM, Keller MA. First example of an FY*01 allele associated with weakened expression of Fy^a on red blood cells. Immunohematology 2015;31:103–7.10.21307/immunohematology-2019-076Search in Google Scholar

14.Beres W, Beauchamp CM, Nickle PA, Singh S, Nance SJ. Comparing the removal of IgG from red blood cells (RBCs) by EDTA glycine acid (EGA) and chloroquine diphosphate (CDP) measured by flow cytometry (FC), tube and gel direct antiglobulin test (DAT) methods. Transfusion 2013;53:2S:181A.Search in Google Scholar

15.Ziman A, Cohn C, Carey PM, et al. Warm-reactive (immunoglobulin G) autoantibodies and laboratory testing best practices: review of the literature and survey of current practice. Transfusion 2017;57:463–77.10.1111/trf.1390327917465Search in Google Scholar